MERCER GLOBAL ADVISORS INC /ADV

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 853758 DENVER, CO

Position in VNDA

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$749,981

+$295,380 QoQ

Shares Held

122,546

+86.3% QoQ

Ownership

0.203%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 172 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 21% Shared 0% None 79%

Healthcare · as of Jun 30, 2026

MERCER GLOBAL ADVISORS INC /ADV holds $302,411,362 across 140 Biotechnology names. VNDA ranks #33 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	941,283	$124,936,492
2	CAPR	Capricor Therapeutics, Inc.	802,732	$19,329,786
3	ORMP	Oramed Pharmaceuticals Inc.	3,810,540	$18,328,697
4	VRTX	Vertex Pharmaceuticals Inc / Ma	30,705	$15,252,094
5	INCY	Incyte Corp	116,207	$13,173,225
6	REGN	Regeneron Pharmaceuticals, Inc.	20,126	$12,549,366
7	EXEL	Exelixis, Inc.	176,339	$9,594,604
8	CORT	Corcept Therapeutics Inc	102,823	$8,940,459

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$749,981	122,546	+86.3%	Shares	Sole	2026-08-19
2026-03-31	$454,601	65,789	+50.1%	Shares	Sole	2026-05-15
2025-12-31	$386,571	43,829	+51.2%	Shares	Sole	2026-02-18
2025-09-30	$144,675	28,993	—	Shares	Sole	2025-11-14
2021-06-30 ALXN	—	16,478	-28.7%	Shares	Sole	2021-08-10
2021-03-31 ALXN	—	23,110	-6.4%	Shares	Sole	2021-08-10
2020-12-31 ALXN	—	24,695	+9.2%	Shares	Sole	2021-02-12
2020-09-30 ALXN	—	22,615	-4.7%	Shares	Sole	2020-12-10
2020-06-30 ALXN	—	23,732	+16.0%	Shares	Sole	2020-08-10
2020-03-31 ALXN	—	20,457	—	Shares	Sole	2020-05-18
No filing history on record for this holder in this stock.